Cognitos technology could pave the way for treatments for neurological conditions like Parkinsons, MS, and traumatic brain injury.On our podcast today, we are joined by Christian Howell, CEO of Cognito Therapeutics
Book online or call or text (310) 291-0013
Claims about human outcomes are extrapolated from animal models without pharmacokinetic or clinical validation
NICE guidance (NG49) emphasises that weight loss remains the cornerstone of NAFLD treatment , with evidence showing that losing 710% of body weight can significantly reduce liver fat, and greater weight loss may improve or resolve NASH and even reverse early fibrosis
The bottom line Copper peptides and GHK-Cu sit at an interesting intersection: enough early science to be genuinely exciting, not yet enough to call them proven
To safeguard the quality of the product and maintain its effectiveness, overnight shipping is required at checkout